Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Polyphenols, a diverse group of naturally occurring compounds found in plants such as fruits, vegetables, tea, coffee, and wine, have attracted scientific interest for their potential neuroprotective effects in Alzheimer’s Disease (AD). Laboratory and animal studies have demonstrated that certain polyphenols, including resveratrol, curcumin, and epigallocatechin gallate (EGCG), may help reduce oxidative stress, inhibit amyloid-beta aggregation, decrease neuroinflammation, and modulate signaling pathways implicated in AD pathology. These mechanisms provide a plausible rationale for their potential use in the prevention or treatment of AD.

However, clinical evidence in humans is limited and generally of low quality. A handful of small randomized controlled trials and observational studies suggest that polyphenol-rich diets or supplements may have modest cognitive benefits or slow cognitive decline, but results are inconsistent and often not statistically significant. Issues such as poor bioavailability, lack of standardized dosing, and heterogeneity in study design further complicate interpretation. Major health bodies do not currently recommend polyphenols specifically for AD treatment. Thus, while there is a scientific basis for further research, the current level of evidence supporting polyphenol use in Alzheimer’s Disease is weak and does not justify clinical use outside of research settings.

More about Polyphenols (npt specified)
More about Alzheimer's Disease

Other ingredients used for Alzheimer's Disease

Other health conditions supported by Polyphenols (npt specified)

Products containing Polyphenols (npt specified)